LAH4 enhances CD8+ T cell immunity of protein/peptide-based vaccines
- 24 November 2011
- journal article
- Published by Elsevier BV in Vaccine
- Vol. 30 (4), 784-793
- https://doi.org/10.1016/j.vaccine.2011.11.056
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- Enhancement of protein vaccine potency by in vivo electroporation mediated intramuscular injectionVaccine, 2011
- Vaccine Adjuvants: Putting Innate Immunity to WorkImmunity, 2010
- Efficient delivery of DNA vaccines using human papillomavirus pseudovirionsGene Therapy, 2010
- Coadministration of a Tumor-Penetrating Peptide Enhances the Efficacy of Cancer DrugsScience, 2010
- Immunotherapy for Cervical CancerBioDrugs, 2010
- Epigallocatechin-3-Gallate Enhances CD8+ T Cell–Mediated Antitumor Immunity Induced by DNA VaccinationCancer Research, 2007
- A non-covalent peptide-based strategy for protein and peptide nucleic acid transductionBiochimica et Biophysica Acta (BBA) - Biomembranes, 2006
- A peptide carrier for the delivery of biologically active proteins into mammalian cellsNature Biotechnology, 2001
- Membrane Helix Orientation from Linear Dichroism of Infrared Attenuated Total Reflection SpectraBiophysical Journal, 1999
- Towards Membrane Protein Design: pH-sensitive Topology of Histidine-containing PolypeptidesJournal of Molecular Biology, 1996